FDA Drug Application (088151) for CHLOROTHIAZIDE W/ RESERPINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number088151
Product Number001
FormTABLET;ORAL
Dosage500MG;0.125MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCHLOROTHIAZIDE W/ RESERPINE
Active IngredientCHLOROTHIAZIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient CHLOROTHIAZIDE10
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by WATSON LABS